日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Current Status of Circulating Tumor DNA Utilization in Australasia: A Survey of Thoracic Oncology Group Australasia Members

澳大利亚及新西兰循环肿瘤DNA利用现状:澳大利亚胸部肿瘤协作组成员调查

Zhu, Yifei; Lo, Danyon; Karikos, Deme; Itchins, Malinda; Wong, Annie

Treatment Patterns, Prognostic Factors and Survival for ALK-Positive Advanced NSCLC In Australia: Results From the Australasian Thoracic Cancers Longitudinal Cohort Study and Biobank (AURORA)

澳大利亚ALK阳性晚期非小细胞肺癌的治疗模式、预后因素和生存情况:来自澳大利亚胸部癌症纵向队列研究和生物样本库(AURORA)的结果

Chazan, Grace; Alexander, Marliese; Franchini, Fanny; IJzerman, Maarten; Shah, Roma; John, Ani; Spelman, Tim; Itchins, Malinda; Pavlakis, Nick; Nagrial, Adnan; Warburton, Lydia; Bowyer, Samantha; Kao, Steven; Parakh, Sagun; Solomon, Benjamin J

Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours

与其他实体瘤相比,胶质瘤患者能够维持疫苗诱导的免疫力。

Yuile, Alexander; Wei, Joe Q; McKelvey, Kelly J; Colvin, Emily K; Zakarya, Razia; Stoner, Shihani P; Jagadeesan, Advaitha; Yunus, Madiha; de Silva, Hasanthi C; Gilson, Josef; Leck, Lionel; Arzuman, Laila; Zhang, Otto; Oatley, Meredith; Pavlakis, Nick; Chan, David I; Itchins, Malinda; Kastelan, Marina; Lee, Adrian; Wheeler, Helen R; Menzies, Alexander; Diakos, Connie I; Guminski, Alexander; Back, Michael; Eade, Thomas; Jayamanne, Dasantha; Kneebone, Andrew; Hudson, Amanda L

ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance

ALKTERNATE:一项在既往ALK抑制剂耐药的ALK阳性非小细胞肺癌患者中交替使用洛拉替尼和克唑替尼的试点研究。

Itchins, Malinda; Liang, Shirley; Brown, Chris; Barnes, Tristan; Marx, Gavin; Chin, Venessa; Kao, Steven; Yip, Po Yee; Mersiades, Antony J; Nagrial, Adnan; Bray, Victoria; Peters, Geoffrey; Parakh, Sagun; Garg, Kavita; Li, Bob T; McKay, Matthew; O'Byrne, Kenneth; John, Thomas; Gill, Anthony J; Molloy, Mark P; Solomon, Benjamin J; Pavlakis, Nick

First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study

非小细胞肺癌脑转移患者的一线化疗免疫疗法和免疫疗法:一项登记研究

Brown, Lauren Julia; Khou, Victor; Brown, Chris; Alexander, Marliese; Jayamanne, Dasantha; Wei, Joe; Gray, Lauren; Chan, Wei Yen; Smith, Samuel; Harden, Susan; Mersiades, Antony; Warburton, Lydia; Itchins, Malinda; Lee, Jenny H; Pavlakis, Nick; Clarke, Stephen J; Boyer, Michael; Nagrial, Adnan; Hau, Eric; Pires da Silva, Ines; Kao, Steven; Kong, Benjamin Y

A Validated Assay to Quantify Osimertinib and Its Metabolites, AZ5104 and AZ7550, from Microsampled Dried Blood Spots and Plasma

通过微量干血斑和血浆样本对奥希替尼及其代谢物 AZ5104 和 AZ7550 进行定量分析的验证方法

Bharat Venkatesh, Alex Yuile, Matthew J McKay, Sathya Narayanan, Helen Wheeler, Malinda Itchins, Nick Pavlakis, Stephen J Clarke, Mark P Molloy

Metastatic Non-Myofibroblastic Sarcoma Harbouring EML4-ALK Fusion-Dramatic Response to ALK Tyrosine Kinase Inhibitors and Development of Resistance Mutations

转移性非肌纤维母细胞肉瘤携带EML4-ALK融合基因——对ALK酪氨酸激酶抑制剂的显著反应及耐药突变的出现

Wilson, Isabella; Qiu, Min; Itchins, Malinda; Wang, Bin; Huang, Min Li; Grimison, Peter

Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-Analysis

抗PD-1单克隆抗体(mAb)联合化疗一线治疗转移性非小细胞肺癌(mNSCLC)优于抗PD-L1 mAb:一项网络荟萃分析

Wei, Joe Q; Yuile, Alexander; Itchins, Malinda; Kong, Benjamin Y; Li, Bob T; Pavlakis, Nick; Chan, David L; Clarke, Stephen J

LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC

欧莱雅澳大利亚:洛拉替尼在晚期ALK重排非小细胞肺癌患者中的真实世界澳大利亚经验

Alexander, Marliese; Wei, Joe; Parakh, Sagun; John, Thomas; Kao, Steven; Nagrial, Adnan; Bowyer, Samantha; Warburton, Lydia; Moore, Melissa; Hughes, Brett G M; Clay, Timothy D; Pavlakis, Nick; Solomon, Benjamin J; Itchins, Malinda

The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer

中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)和淋巴细胞与单核细胞比值(LMR)作为胰腺癌切除术后生物标志物的预后和预测作用

Maloney, Sarah; Pavlakis, Nick; Itchins, Malinda; Arena, Jennifer; Mittal, Anubhav; Hudson, Amanda; Colvin, Emily; Sahni, Sumit; Diakos, Connie; Chan, David; Gill, Anthony J; Samra, Jaswinder; Clarke, Stephen J